Diazoxide Suspension
Product Images NDC 13517-100

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Diazoxide (NDC 13517-100). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by E5 Pharma, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Figure 01)

Chemical Structure (Figure 01)
Chemical structure of diazoxide, showing a benzene ring with a chlorine atom, sulfonamide group, and an imidazoline ring with a methyl substitution, consistent with the active ingredient diazoxide.*
FDA Label Image

Diazoxide Oral Suspension, Usp 50 mg/ml, 30 mL Carton (Figure 02)

Diazoxide Oral Suspension, Usp  50 mg/ml, 30 mL Carton (Figure 02)
Diazoxide Oral Suspension, USP 50 mg per mL in a 1 fl oz (30 mL) carton by e5 Pharma, LLC. The label shows the NDC number 13517-100-30, lists inactive ingredients, storage instructions, dosage guidance, and a caution to use the enclosed child-resistant dropper. Manufactured by e5 Pharma, Boca Raton, FL. Contains alcohol and is for oral use only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.